Genome-wide analysis of histone modifications in latently HIV-1 infected T cells

AIDS

Volumn 28, Issue 12, 2014, Pages 1719-1728

  Park, Jihwan ^a   Lim, Chae Hyun ^b   Ham, Seokjin ^a   Kim, Sung Soon ^c   Choi, Byeong Sun ^c   Roh, Tae Young ^a,b  

^a Department of Life Sciences ^*  (South Korea)

^b Pohang University of Science and Technology (POSTECH)   (South Korea)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

chromatin; epigenetics; epigenome; histone modifications; HIV type 1; network analysis; viral latency

Indexed keywords

CYCLIN D2; CYCLIN DEPENDENT KINASE INHIBITOR 1A; HISTONE; HISTONES;

ARTICLE; CELL CYCLE REGULATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; EPIGENETICS; GENE CLUSTER; GENE EXPRESSION; GENE SEQUENCE; GENETIC ASSOCIATION; HISTONE MODIFICATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; NONHUMAN; PRIORITY JOURNAL; REGULATOR GENE; T LYMPHOCYTE; TRANSCRIPTION REGULATION; UPREGULATION; VIRAL CLEARANCE; VIRUS LATENCY; EPIGENESIS, GENETIC; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; HIV INFECTIONS; HIV-1; HUMANS; METABOLISM; PHYSIOLOGY; PROTEIN PROCESSING, POST-TRANSLATIONAL; SEQUENCE ANALYSIS, DNA; T-LYMPHOCYTES; VIROLOGY;

CHROMATIN IMMUNOPRECIPITATION; EPIGENESIS, GENETIC; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; HISTONES; HIV INFECTIONS; HIV-1; HUMANS; PROTEIN PROCESSING, POST-TRANSLATIONAL; SEQUENCE ANALYSIS, DNA; T-LYMPHOCYTES; VIRUS LATENCY;

EID: 84904203975     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000309     Document Type: Article

References (31)

1. Chun TW, Davey RT Jr, Engel D, Lane HC, Fauci AS. Reemergence of HIV after stopping therapy. Nature 1999 401874-875.
2. Roh TY, Ngau WC, Cui K, Landsman D, Zhao K. High-resolution genome-wide mapping of histone modifications. Nat Biotechnol 2004 221013-1016.
3. Roh TY, Cuddapah S, Zhao K. Active chromatin domains are defined by acetylation islands revealed by genome-wide mapping. Genes Dev 2005 19542-552.
4. Barski A, Cuddapah S, Cui KR, Roh TY, Schones DE, Wang ZB, et al. High-resolution profiling of histone methylations in the human genome. Cell 2007 129823-837.
5. Schones DE, Cui K, Cuddapah S, Roh TY, Barski A, Wang Z, et al. Dynamic regulation of nucleosome positioning in the human genome. Cell 2008 132887-898.
6. Jones PA. Functions of DNA methylation islands, start sites, gene bodies and beyond. Nat Rev Genet 2012 13484-492.
7. Yavartanoo M, Choi JK. ENCODE a sourcebook of epigenomes and chromatin language. Genomics Inform 2013 11 2-6.
8. Hong CP, Choe MK, Roh TY. Characterization of chromatin structure-associated histone modifications in breast cancer cells. Genomics Inform 2012 10145-152.
9. Black JC, Van Rechem C, Whetstine JR. Histone lysine methylation dynamics establishment, regulation, and biological impact. Molecular Cell 2012 48491-507.
10. MacDonald VE, Howe LJ. Histone acetylation where to go and how to get there. Epigenetics 2009 4139-143.
11. Ay E, Banati F, Mezei M, Bakos A, Niller HH, Buzas K, et al. Epigenetics of HIV infection promising research areas and implications for therapy. AIDS Rev 2013 15181-188.
12. Gordon S, Akopyan G, Garban H, Bonavida B. Transcription factor YY1 structure, function, and therapeutic implications in cancer biology. Oncogene 2006 251125-1142.
13. Ylisastigui L, Coull JJ, Rucker VC, Melander C, Bosch RJ, Brodie SJ, et al. Polyamides reveal a role for repression in latency within resting T cells of HIV-infected donors. J Infect Dis 2004 1901429-1437.
14. Williams SA, Chen LF, Kwon H, Ruiz-Jarabo CM, Verdin E, Greene WC. NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation. EMBO J 2006 25139-149.
15. Jiang G, Espeseth A, Hazuda DJ, Margolis DM. c-Myc and Sp1 contribute to proviral latency by recruiting histone deacetylase 1 to the human immunodeficiency virus type 1 promoter. J Virol 2007 8110914-10923.
16. Donahue DA, Kuhl BD, Sloan RD, Wainberg MA. The viral protein Tat can inhibit the establishment of HIV-1 latency. J Virol 2012 863253-3263.
17. Roh TY, Cuddapah S, Cui K, Zhao K. The genomic landscape of histone modifications in human T cells. Proc Natl Acad Sci USA 2006 10315782-15787.
18. Roh TY, Wei G, Farrell CM, Zhao K. Genome-wide prediction of conserved and nonconserved enhancers by histone acetylation patterns. Genome Res 2007 1774-81.
19. Kim HG, Kim KC, Roh TY, Park J, Jung KM, Lee JS, et al. Gene silencing in HIV-1 latency by polycomb repressive group. Virol J 2011 8179.
20. Kim KC, Kim HG, Roh TY, Park J, Jung KM, Lee JS, et al. The effect of CD4 receptor downregulation and its downstream signaling molecules on HIV-1 latency. Biochem Biophys Res Commun 2011 404646-651.
21. Choe MK, Hong CP, Park J, Seo SH, Roh TY. Functional elements demarcated by histone modifications in breast cancer cells. Biochem Biophys Res Commun 2012 418475-482.
22. Zang C, Schones DE, Zeng C, Cui K, Zhao K, Peng W. A clustering approach for identification of enriched domains from histone modification ChIP-Seq data. Bioinformatics 2009 251952-1958.
23. Bader GD, Hogue CW. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics 2003 42.
24. Maere S, Heymans K, Kuiper M. BiNGO a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics 2005 213448-3449.
25. Oh YT, Kim KC, Hong KJ, Lee HS, Jang DH, Lee JS, et al. Establishment of novel cell lines latently infected with human immunodeficiency virus 1. Acta Virol 2011 55155-159.
26. Brady T, Agosto LM, Malani N, Berry CC, O'Doherty U, Bushman F. HIV integration site distributions in resting and activated CD4R T cells infected in culture. AIDS 2009 231461-1471.
27. Wang GP, Ciuffi A, Leipzig J, Berry CC, Bushman FD. HIV integration site selection analysis by massively parallel pyrosequencing reveals association with epigenetic modifications. Genome Res 2007 171186-1194.
28. Pace MJ, Agosto L, Graf EH, O'Doherty U. HIV reservoirs and latency models. Virology 2011 411344-354.
29. Sherrill-Mix S, Lewinski MK, Famiglietti M, Bosque A, Malani N, Ocwieja KE, et al. HIV latency and integration site placement in five cell-based models. Retrovirology 2013 1090.
30. Fernandez G, Zeichner SL. Cell line-dependent variability in HIV activation employing DNMT inhibitors. Virol J 2010 7266.
31. Coiras M, Lopez-Huertas MR, Perez-Olmeda M, Alcami J. Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs. Nat Rev Microbiol 2009 7798-812. Institute of Health